| Literature DB >> 36262168 |
Atefeh Amerizadeh1,2, Golnaz Vaseghi2, Nazgol Esmaeilian2, Sedigheh Asgary1.
Abstract
Cydonia oblonga Miller (quince) is a monotypic genus in the Rosaceae family which used to treat or prevent many medical conditions such as diabetes, cancer, infections, and ulcer. This review will summarize the current state of knowledge available on botany, phytochemistry, and pharmacology of this plant with a focus on its effect on some cardiovascular risk factors such as diabetes, blood pressure, lipid profile, and body weight. Databases of Google Scholar, Web of Science, PubMed, Scopus, and SID were searched systematically for English published articles with no date limitation. There were no human studies found, and all of the studies were conducted on animals or in vitro models. Reviewing of all 12 included articles showed that different types of quince extract have positive effects on cardiovascular-related factors such as blood pressure, diabetes, glucose metabolism, lipid profile, ROS, body weight, liver dysfunction, and thrombosis. An antihypertensive effect of quince showed to be a magnitude that is comparable to captopril and the lipid-lowering effect of quince showed to be a magnitude that is comparable to simvastatin. However, two studies evaluated the effect of quince fruit extract on insulin levels; one of them reported no positive effect, and the other one reported a significant positive effect. It can be concluded that different parts of quince including leaf, seed, and fruit could be used for improving cardiovascular-related factors including blood pressure, glucose metabolism and diabetes, obesity, and lipid-adjusting purposes. Quince was also found to have strong anti-inflammatory and antioxidant capacity. This study paves the way for further studies on the cardiovascular effect of quince consumption as a beneficial nutraceutical in humans.Entities:
Year: 2022 PMID: 36262168 PMCID: PMC9576383 DOI: 10.1155/2022/3185442
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.650
Figure 1Flowchart of study selection.
Included studies on Cydonia oblonga Miller.
| Authors, Year | Model | Intervention | Duration | Studied factors | Results |
|---|---|---|---|---|---|
| Zhou et al. [ | Renal hypertensive rat | Captopril administration 25 mg/kg/day | 8 weeks | SBP&DBP | Blood pressure was considerably and dose-dependently lowered by COM leaf extracts. |
| Abliz et al. [ | Sprague–Dawley rats received high-fat diet | Simvastatin administration | 56 days | Lipid profile | COM reduced TC, TG, LDL-C and increased HDL-C dose-dependently. |
| Zhou et al. [ | Mice | Aspirin 5 mg/kg/day | 2 weeks | Bleeding and clotting times | In comparison to aspirin, COM extracts prolonged bleeding and clotting times in a dose-dependent manner. |
| Khademi et al. [ | Rabbits | Atorvastatin (0.5 mg/kg) | 12 weeks | Biopsy of coronary artery | Treatment with the COM extract at 50 mg/kg and 0.5 mg/kg atorvastatin lowered plasma lipid profile ( |
| Khademi et al. [ | Hypercholsterolemic rabbits | Atorvastatin (0.5 mg/kg) | 8 weeks | Lipid profileLiver enzymes | Treatment with the COM extract at 50 mg/kg and 0.5 mg/kg atorvastatin lowered plasma lipid profile ( |
| Mirmohammadlu et al. [ | Diabetic rats | Various doses of aqueous extract of COM fruit | Lipid profile, AST, ALT, AP, BUN, Cr | LDL, TC, TG were significantly decreased. | |
| Aslan et al. [ | Healthy and diabetic rats | Various doses of COM leaf extract | 5 days | Fasting blood glucose | Blood glucose levels dropped by 33.8 percent |
| Tang et al. [ | L6 skeletal muscle cells | Various doses of COM seed extract | 1 h | Glucose consumption and glycogen synthesis | At 12.5 g/ml, glucose intake and glycogen production was boosted |
| Umar et al. [ | Hyperlipidaemic rats | Various doses of total leaves COM flavonoids | 4 weeks | Lipid profile, Liver enzymes | Total flavonoids from COM fruit and leaves dramatically lowered TC, TG, LDL, ALT, AST, and MDA while considerably increasing HDL. |
| Mohebbi et al. [ | Diabetic rats | Various doses of COM fruit aqueous extract | 28 days | Fasting blood glucose | A significant collapse in FBG in a dose-dependent manner |
| Ur rahman et al. [ | Normotensive, high cholesterol, and glucose fed hypertensive rats | COM extract in 200, 400, and 600 mg/kg dose | 21 days | SBP, DBP | SBP decreased significantly in a dose-dependent manner. |
| Lee et al. [ | High-fat diet (HFD)-induced obese C57BL/6 mice | HFD + 50 mg/kg BW/day COM (COM 50) | 8 weeks | Body weight, fat mass, adipose tissue weight, lipid profile, and leptin | COM showed an anti-obesity effect. |
COM: Cydonia oblonga Miller, ALT: alanine transaminase, AST: aspartate transaminase, ALP: alkaline phosphatase, FBG: fasting blood glucose, SBP: systolic blood pressure, DBP: diastolic blood pressure, TC: total cholesterol, LDL: low-density lipoprotein, HDL: high-density lipoprotein, TG: triglycerides.